nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0439	0.0688	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0439	0.0688	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.036	0.0565	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0339	0.0531	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0339	0.0531	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0333	0.0522	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0333	0.0522	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0319	0.05	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0306	0.048	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0306	0.048	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0264	0.0414	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0257	0.0402	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0232	0.0364	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0232	0.0364	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0223	0.0349	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0209	0.0328	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0197	0.0309	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0197	0.0309	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0178	0.0279	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0178	0.0279	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0154	0.0241	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0149	0.0234	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0135	0.0212	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0135	0.0212	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0129	0.0203	CbGbCtD
Medroxyprogesterone Acetate—SHBG—semen—acquired immunodeficiency syndrome	0.00728	0.099	CbGeAlD
Medroxyprogesterone Acetate—AR—semen—acquired immunodeficiency syndrome	0.00523	0.0711	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—digestive system—acquired immunodeficiency syndrome	0.00322	0.0437	CbGeAlD
Medroxyprogesterone Acetate—SHBG—blood plasma—acquired immunodeficiency syndrome	0.00265	0.0361	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—nervous system—acquired immunodeficiency syndrome	0.00249	0.0338	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—acquired immunodeficiency syndrome	0.0024	0.0326	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—brain—acquired immunodeficiency syndrome	0.0019	0.0259	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—acquired immunodeficiency syndrome	0.00184	0.025	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nerve—acquired immunodeficiency syndrome	0.00182	0.0248	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00154	0.0209	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—blood plasma—acquired immunodeficiency syndrome	0.00138	0.0188	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00137	0.0186	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—blood—acquired immunodeficiency syndrome	0.00129	0.0176	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—bone marrow—acquired immunodeficiency syndrome	0.00125	0.017	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—spinal cord—acquired immunodeficiency syndrome	0.00125	0.0169	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—vagina—acquired immunodeficiency syndrome	0.0012	0.0163	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lung—acquired immunodeficiency syndrome	0.00113	0.0154	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00104	0.0142	CbGeAlD
Medroxyprogesterone Acetate—SHBG—blood—acquired immunodeficiency syndrome	0.000972	0.0132	CbGeAlD
Medroxyprogesterone Acetate—SHBG—bone marrow—acquired immunodeficiency syndrome	0.000941	0.0128	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymphoid tissue—acquired immunodeficiency syndrome	0.000931	0.0127	CbGeAlD
Medroxyprogesterone Acetate—AR—skin of body—acquired immunodeficiency syndrome	0.000916	0.0124	CbGeAlD
Medroxyprogesterone Acetate—SHBG—vagina—acquired immunodeficiency syndrome	0.000901	0.0123	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood—acquired immunodeficiency syndrome	0.000876	0.0119	CbGeAlD
Medroxyprogesterone Acetate—PGR—vagina—acquired immunodeficiency syndrome	0.000812	0.011	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—acquired immunodeficiency syndrome	0.000802	0.0109	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lymph node—acquired immunodeficiency syndrome	0.000775	0.0105	CbGeAlD
Medroxyprogesterone Acetate—PGR—lung—acquired immunodeficiency syndrome	0.000768	0.0104	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—acquired immunodeficiency syndrome	0.00076	0.0103	CbGeAlD
Medroxyprogesterone Acetate—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000741	0.0101	CbGeAlD
Medroxyprogesterone Acetate—AR—digestive system—acquired immunodeficiency syndrome	0.000732	0.00996	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.000728	0.00989	CbGeAlD
Medroxyprogesterone Acetate—ESR1—digestive system—acquired immunodeficiency syndrome	0.000719	0.00977	CbGeAlD
Medroxyprogesterone Acetate—PGR—nervous system—acquired immunodeficiency syndrome	0.000711	0.00966	CbGeAlD
Medroxyprogesterone Acetate—AR—blood—acquired immunodeficiency syndrome	0.000698	0.00949	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood—acquired immunodeficiency syndrome	0.000685	0.00931	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—acquired immunodeficiency syndrome	0.000684	0.00931	CbGeAlD
Medroxyprogesterone Acetate—AR—spinal cord—acquired immunodeficiency syndrome	0.000672	0.00914	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—skin of body—acquired immunodeficiency syndrome	0.000663	0.00902	CbGeAlD
Medroxyprogesterone Acetate—AR—vagina—acquired immunodeficiency syndrome	0.000647	0.00879	CbGeAlD
Medroxyprogesterone Acetate—ESR1—vagina—acquired immunodeficiency syndrome	0.000635	0.00863	CbGeAlD
Medroxyprogesterone Acetate—AR—lung—acquired immunodeficiency syndrome	0.000612	0.00832	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—acquired immunodeficiency syndrome	0.000603	0.0082	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lung—acquired immunodeficiency syndrome	0.0006	0.00816	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—acquired immunodeficiency syndrome	0.000566	0.0077	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—blood—acquired immunodeficiency syndrome	0.000564	0.00767	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—acquired immunodeficiency syndrome	0.000556	0.00756	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—acquired immunodeficiency syndrome	0.000545	0.00741	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—acquired immunodeficiency syndrome	0.000543	0.00739	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymphoid tissue—acquired immunodeficiency syndrome	0.000537	0.0073	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—acquired immunodeficiency syndrome	0.000535	0.00728	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—digestive system—acquired immunodeficiency syndrome	0.00053	0.00721	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000526	0.00715	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymph node—acquired immunodeficiency syndrome	0.000525	0.00714	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000523	0.00711	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—blood—acquired immunodeficiency syndrome	0.000505	0.00687	CbGeAlD
Medroxyprogesterone Acetate—CYP2C9—blood—acquired immunodeficiency syndrome	0.000501	0.00681	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—bone marrow—acquired immunodeficiency syndrome	0.000489	0.00665	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—spinal cord—acquired immunodeficiency syndrome	0.000487	0.00662	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—vagina—acquired immunodeficiency syndrome	0.000468	0.00637	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lung—acquired immunodeficiency syndrome	0.000443	0.00602	CbGeAlD
Medroxyprogesterone Acetate—AR—brain—acquired immunodeficiency syndrome	0.000433	0.00589	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brain—acquired immunodeficiency syndrome	0.000425	0.00578	CbGeAlD
Medroxyprogesterone Acetate—AR—lymph node—acquired immunodeficiency syndrome	0.000418	0.00569	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymph node—acquired immunodeficiency syndrome	0.000411	0.00558	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nervous system—acquired immunodeficiency syndrome	0.00041	0.00558	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000401	0.00545	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—acquired immunodeficiency syndrome	0.000395	0.00537	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—blood—acquired immunodeficiency syndrome	0.000382	0.0052	CbGeAlD
Medroxyprogesterone Acetate—CYP2C8—brain—acquired immunodeficiency syndrome	0.00035	0.00476	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brain—acquired immunodeficiency syndrome	0.000314	0.00426	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00031	0.00422	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymph node—acquired immunodeficiency syndrome	0.000303	0.00412	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000299	0.00406	CbGeAlD
Medroxyprogesterone Acetate—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000112	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000388	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000387	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000386	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000384	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000384	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00011	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000381	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000378	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000109	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000109	0.000377	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000108	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000375	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000373	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000372	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000107	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.00037	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000369	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000367	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000364	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000105	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000363	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000104	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00036	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000359	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000358	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000357	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000356	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000355	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000353	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000101	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000101	0.000349	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000349	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000347	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.99e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Stavudine—acquired immunodeficiency syndrome	9.98e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.98e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.97e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.97e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.96e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.95e-05	0.000345	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Stavudine—acquired immunodeficiency syndrome	9.92e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.92e-05	0.000344	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9.91e-05	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.89e-05	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.89e-05	0.000343	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.87e-05	0.000342	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Abacavir—acquired immunodeficiency syndrome	9.84e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.83e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.000341	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.82e-05	0.00034	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Abacavir—acquired immunodeficiency syndrome	9.77e-05	0.000339	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Lamivudine—acquired immunodeficiency syndrome	9.76e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	9.75e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.74e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.74e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.68e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Lamivudine—acquired immunodeficiency syndrome	9.67e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	9.64e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.62e-05	0.000334	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.62e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.61e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.61e-05	0.000333	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.56e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	9.56e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	9.54e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	9.54e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	9.54e-05	0.000331	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Ritonavir—acquired immunodeficiency syndrome	9.51e-05	0.00033	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.5e-05	0.000329	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.46e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.43e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.43e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.42e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.42e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Stavudine—acquired immunodeficiency syndrome	9.41e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.38e-05	0.000325	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.37e-05	0.000325	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000323	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.3e-05	0.000322	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Abacavir—acquired immunodeficiency syndrome	9.27e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.25e-05	0.000321	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.24e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.23e-05	0.00032	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.19e-05	0.000319	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.18e-05	0.000318	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.18e-05	0.000318	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.18e-05	0.000318	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.16e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.15e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.15e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.15e-05	0.000317	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.1e-05	0.000315	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.07e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.06e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.95e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.95e-05	0.00031	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.91e-05	0.000309	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.89e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.89e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.88e-05	0.000308	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.000306	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.82e-05	0.000306	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.81e-05	0.000305	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.76e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.76e-05	0.000304	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.75e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Lamivudine—acquired immunodeficiency syndrome	8.73e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Zidovudine—acquired immunodeficiency syndrome	8.68e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.68e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.67e-05	0.000301	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.65e-05	0.0003	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Zidovudine—acquired immunodeficiency syndrome	8.62e-05	0.000299	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.56e-05	0.000297	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.54e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.53e-05	0.000296	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.5e-05	0.000295	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.49e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.48e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.47e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.46e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.46e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.46e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.42e-05	0.000292	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.4e-05	0.000291	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.3e-05	0.000288	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.27e-05	0.000287	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.19e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.18e-05	0.000284	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.18e-05	0.000283	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.14e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.14e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.14e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.1e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Indinavir—acquired immunodeficiency syndrome	8.07e-05	0.00028	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.06e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.03e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Indinavir—acquired immunodeficiency syndrome	8.02e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8e-05	0.000277	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.92e-05	0.000274	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.88e-05	0.000273	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.81e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.77e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.77e-05	0.000269	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.69e-05	0.000267	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000266	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.65e-05	0.000265	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Efavirenz—acquired immunodeficiency syndrome	7.63e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Indinavir—acquired immunodeficiency syndrome	7.6e-05	0.000264	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.59e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Efavirenz—acquired immunodeficiency syndrome	7.58e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.57e-05	0.000262	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.39e-05	0.000256	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.36e-05	0.000255	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000254	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Delavirdine—acquired immunodeficiency syndrome	7.3e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.29e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.29e-05	0.000253	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Delavirdine—acquired immunodeficiency syndrome	7.25e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.24e-05	0.000251	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.18e-05	0.000249	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.08e-05	0.000245	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.05e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.95e-05	0.000241	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.87e-05	0.000238	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.8e-05	0.000236	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Ritonavir—acquired immunodeficiency syndrome	6.75e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.74e-05	0.000234	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.000233	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Ritonavir—acquired immunodeficiency syndrome	6.7e-05	0.000232	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000227	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000225	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Saquinavir—acquired immunodeficiency syndrome	6.45e-05	0.000224	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.00022	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000217	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000215	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Lamivudine—acquired immunodeficiency syndrome	6.16e-05	0.000213	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.12e-05	0.000212	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000202	CcSEcCtD
